Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I)

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

March 31, 2017

Conditions
Coronary Artery Disease
Interventions
DEVICE

Shockwave Coronary Rx Lithoplasty® System

The Shockwave Coronary Rx Lithoplasty® System is a proprietary balloon catheter system designed to deliver localized, lithotripsy-enhanced, balloon dilatation of calcified, stenotic, de novo coronary arteries. Energizing the lithotripsy electrodes will generate pulsatile mechanical energy within the target treatment site and will disrupt calcium within the lesion and allow subsequent dilatation of a coronary artery stenosis using low balloon pressure. The system consists of a rapid exchange balloon catheter with integrated, internal lithotripsy electrodes and a Shockwave generator.

Trial Locations (7)

22185

Skane University Hospital- Lund, Lund

VIC 3168

Monash Heart, Monash Health, Clayton

VIC 3065

St. Vincent's Hospital, Melbourne

BP 27617

Clinic Pastuer, Toulouse

3000 CA

Thoraxcenter, Erasmus MC, Rotterdam

SE5 9RS

King's College Hospital, London

SW3 6NP

Royal Brompton Hospital, London

All Listed Sponsors
lead

Shockwave Medical, Inc.

INDUSTRY

NCT02650128 - Shockwave Coronary Rx Lithoplasty® Study (Disrupt CAD I) | Biotech Hunter | Biotech Hunter